Related Experiment Video
Updated: Aug 10, 2026

07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Progress against cancer: are we winning the war?
1ICRF Cancer Epidemiology and Clinical Trials Unit, Radcliffe Infirmary, Oxford, England.
Acta Oncologica (Stockholm, Sweden)
|January 1, 1989
Summary
Cancer mortality trends are best assessed in younger populations to reveal recent progress. While overall trends may mislead, analysis of younger age groups shows mostly encouraging cancer survival rates, with some areas needing further research and preventive action.
Area of Science:
- Oncology
- Biostatistics
- Public Health
Background:
- Overall age-standardized cancer mortality trends can be misleading.
- Past environmental and behavioral changes impact cancer incidence in older populations.
- Recent advancements in cancer treatment, behavior, and environment are best reflected in younger age groups.
Purpose of the Study:
- To reassess the conclusion that 'cancer as a whole we have lost ground'.
- To evaluate recent progress in cancer care by examining age-specific mortality trends.
- To identify areas requiring preventive action or further research based on current cancer trends.
Main Methods:
- Analysis of age-specific cancer mortality trends.
- Comparison of trends across different age demographics.
- Evaluation of the impact of recent changes on cancer incidence and mortality.
Main Results:
- Age-standardized mortality trends across all ages may obscure recent progress.
- Cancer mortality trends in younger populations are predominantly encouraging.
- Specific cancer types in younger demographics indicate a need for targeted interventions.
Conclusions:
- Recent progress in cancer care is evident when examining younger age groups.
- A few specific cancer trends necessitate urgent preventive strategies and research.
- Focusing on age-specific data provides a more accurate assessment of cancer control effectiveness.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

